Results 241 to 250 of about 14,337,199 (401)

Correction: Research progress on nanomaterial-empowered electrochemical biosensors for the detection of cardiac troponin I. [PDF]

RSC Adv
Zhang N, Zhu Y, Li F, Wang Y, Fu Z, Jia M, Zhan X, Zhang W.   +7 more
europepmc   +1 more source

Highly specific immunoassay for cardiac troponin I assessed in noninfarct patients with chronic renal failure or severe polytrauma

, 1995
Sylvie Trinquier, O Flécheux, M Bullenger, F. Castex   +3 more
openalex   +1 more source

Increased Concentrations of Cardiac Troponin I Are Equivalent to Increased Cardiac Troponin T in Identifying Chest Pain Patients at Short-Term Risk of Myocardial Infarction [PDF]

, 1998
Barry Bluestein, George H. Parsons, Kimberly A. Foster   +2 more
openalex   +1 more source

High‐sensitivity cardiac troponin after cardiac stress test: A systematic review and meta‐analysis [PDF]

, 2019
Avila, Audrey, Ben Abdallah, Arbi, Helwani, Mohammad A, Jaffe, Allan S, Nagele, Peter, Samaha, Eslam, Scott, Mitchell G   +6 more
core   +1 more source

A new staging system for hereditary transthyretin amyloidosis in the era of specific amyloidosis therapies

ESC Heart Failure, EarlyView.
The aim of our study was to develop a more accurate staging system for hereditary ATTR patients currently receiving specific treatment. A staging system was created using as criteria: GLS ≤ −11%, NT‐proBNP ≤ 2,000 ng/L, and eGFR ≤ 65 mL/min. We managed to accurately stratify patients into three disease stages, significantly different in terms of ...
Gabriela Neculae, Amira Zaroui, Robert Adam, Mounira Kharoubi, Benoit Funalot, Daniel Coriu, Ruxandra Jurcut, Thibaud Damy   +7 more
wiley   +1 more source

Early prediction of sepsis-induced cardiorenal syndrome: superiority of myoglobin over troponin I. [PDF]

Ren Fail
Liu Y, Zheng C, Liu X, Zhang XQ, Zhang Y, Yu C.   +5 more
europepmc   +1 more source

Galectin‐3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE‐TIMI 58

ESC Heart Failure, EarlyView.
Abstract Background Galectin‐3 (Gal‐3) is a circulating biomarker of fibrosis, with higher levels being associated with an increased risk of progression of heart failure and kidney disease. Patients with type 2 diabetes mellitus (T2DM) are at increased risk of both.
Paul M. Haller, Stephen D. Wiviott, David D. Berg, Petr Jarolim, Erica L. Goodrich, Deepak L. Bhatt, Ingrid Gause‐Nilsson, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Itamar Raz, Marc S. Sabatine, David A. Morrow   +12 more
wiley   +1 more source

Research progress on nanomaterial-empowered electrochemical biosensors for the detection of cardiac troponin I. [PDF]

RSC Adv
Zhang N, Zhu Y, Li F, Wang Y, Fu Z, Jia M, Zhan X, Zhang W.   +7 more
europepmc   +1 more source

High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury

Annals of Clinical Biochemistry, 2017
Melissa Jones, P. O'gorman, C. Kelly, N. Mahon, M. Fitzgibbon   +4 more
semanticscholar   +1 more source

HIF1α-dependent mitophagy facilitates cardiomyoblast differentiation [PDF]

, 2020
Allen, George F. G., Ganley, Ian G., Rodger, Catherine E., Weidlich, Simone, Zhao, Jin-Feng   +4 more
core   +2 more sources